NBIS stock holds a bearish daily bias, trading below its key exponential averages and the lower Bollinger band. The hourly chart confirms the weak structure, but a positive MACD histogram complicates the picture. The bullish case hinges on reclaiming overhead levels, not on momentum alone.
On Friday, October 16, 2026, the stock opened at $181.55 and traded between a low of $175.35 and a high of $182.48. It was trading at $177.24 as of 10:38 ET, down 5.93% versus the previous close. The session remained open. The daily candle opened at $181.55, traded between a low of $175.35 and a high of $182.48, and was last at $177.24, against a previous close of $188.41.
Key takeaways
- NBIS stock was trading at $177.24 as of 10:38 ET on Friday, down 5.93% from the previous close.
- Price sits below the daily 200-session EMA ($181.72), 20-session EMA ($215.22), and 50-session EMA ($218.78).
- Daily RSI14 is 33.38 and daily MACD histogram is -6.74, with the MACD line at -8.81 below its signal at -2.07.
- Hourly RSI14 is 36.89 and hourly MACD histogram is 0.89, with the MACD line at -8.18 above its signal at -9.07.
- Price is below the daily pivot at $180.37, above daily S1 at $171.4, and above the 15-minute pivot at $176.27.
NBIS stock: Daily structure favors the bearish case
The daily chart supports a bearish reading for NBIS stock. Price sits below all three principal exponential averages and the daily pivot.
Specifically, the price is below the daily 200-session EMA at $181.72, the 20-session EMA at $215.22, and the 50-session EMA at $218.78. This places all three averages overhead. However, their ordering is not a fully bearish stack, because the 200-session average sits below the other two.
Meanwhile, daily RSI14 stands at 33.38, below 50 but not oversold. The daily MACD line is -8.81, below its signal at -2.07, with a negative histogram of -6.74. Both readings support the bearish daily assessment.
The daily lower Bollinger band is $184.48, above the current price, while the mid-band stands at $224.27. Price is therefore outside the lower side of the daily envelope. Daily ATR14 reads $16.54, providing a volatility reference.
Notably, price is also below the daily pivot at $180.37 and above daily first support (S1) at $171.4. Daily first resistance (R1) stands at $197.37. These levels derive from the previous completed daily candle and apply to the current session.
Hourly confirmation, but not unanimous momentum
The hourly chart largely confirms the bearish structure, though momentum signals are split.
On the hourly chart, price sits below the 20-hour EMA at $187.28 and the 50-hour EMA at $202.44. It also trades below the 200-hour EMA at $219.55. Their ordering forms a complete bearish stack. Price sits below the hourly Bollinger mid-band at $186.9, but above its lower band at $164.46.
However, hourly momentum is mixed. RSI14 is 36.89, below 50, while the MACD line at -8.18 is above its signal at -9.07. The positive histogram of 0.89 offers a counterweight to the bearish structure, not confirmation of a bullish trend.
15-minute execution context
For short-term timing, the 15-minute chart places price above its pivot at $176.27 and first resistance (R1) at $177.06. Yet price remains below its 20-quarter-hour EMA at $180.41 and Bollinger mid-band at $180.94. RSI14 is 42.66, while the MACD histogram is -0.65. This execution timeframe lacks broad bullish confirmation.
Conflicting coverage and conditional scenarios
Analyst views on Nebius Group diverge, while the technical scenarios remain conditional on key levels.
Contrasting analyst views
Separately, reports published on October 15 presented contrasting views of Nebius. One described a bullish Rosenblatt research note, with John McPeake recommending NBIS shares. A Seeking Alpha article carried a rating downgrade.
Bullish and bearish scenarios
The bullish scenario requires price to hold above the 15-minute pivot at $176.27 and clear the hourly pivot at $177.94. Reclaiming the daily pivot at $180.37 would then put the daily 200-session EMA at $181.72 in focus. Acceptance above the daily lower Bollinger band at $184.48 would provide further support.
In contrast, a break below $176.27 would undermine that bullish sequence and expose the session low at $175.35. A breach of that low would leave hourly first support (S1) at $173.41 ahead of daily first support at $171.4. Remaining below the daily pivot would preserve the bearish main scenario.
Overall, NBIS stock stands below the daily pivot and its key daily averages, with daily ATR14 at $16.54 framing the volatility context. The hourly MACD offers a conflicting signal, but price structure remains bearish. Whether price can reclaim $180.37 and $181.72 remains unresolved while the session is open.
FAQ
What is the current price of NBIS stock?
NBIS stock was trading at $177.24 as of 10:38 ET on Friday, October 16, 2026, down 5.93% from the previous close. The session remained open.
Is NBIS stock in a bearish trend?
The daily chart shows bearish structure. Price sits below the 200-session EMA at $181.72, the 20-session EMA at $215.22, and the 50-session EMA at $218.78. Daily RSI14 is 33.38 and the daily MACD histogram is -6.74.
What are the key levels to watch for NBIS stock?
Key levels include the daily pivot at $180.37, daily S1 at $171.4, daily R1 at $197.37, the 15-minute pivot at $176.27, and the hourly pivot at $177.94. The daily 200-session EMA at $181.72 is also a significant reference.
What do the momentum indicators show?
Daily momentum is bearish, with RSI14 at 33.38 and the MACD histogram at -6.74. Hourly momentum is mixed: RSI14 is 36.89, while the hourly MACD histogram is 0.89, with the MACD line above its signal.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.